|
||||||||||||||||||
 |
From: TSS ()
Concerns Over BSE, or Mad Cow Disease and FDA Regulation Has Contributed to Decreased Use of (FBS) Fetal Bovine Serum in Biomanufacturing Research and Markets (http://www.researchandmarkets.com/reports/c39059) has announced the addition of Cell Culture: Media, Sera, and Reagents to their offering The culturing of cells requires nutrients from media, sera, and reagents and is used for research, process development, and biomanufacturing purposes. In recent years, with ongoing consolidation activity, the market has been dominated by fewer major suppliers, led by Invitrogen, Fisher Scientific (with its HyClone subsidiary), and JRH Biosciences. Only the largest players can compete as suppliers in the therapeutic production and manufacturing space, but smaller players, particularly Mediatech (with its Cellgro brand), are gaining significant market share in academic and industry research segments. Niche markets like stem cell research will grow in size and importance, given encouraging news like the recent $3 billion voter-approved bond in California to fund stem cell research over the next ten years. In addition, media consumption levels, especially for specialty and custom serum-free formulations, are on the rise, fuelled by biologics like monoclonal antibodies, vaccines, and recombinant proteins that are in the pipeline or commercially marketed. In parallel, fetal bovine serum (FBS) use has decreased significantly in biomanufacturing applications, due to concerns over Bovine Spongiform Encelphalopathy (BSE, or Mad Cow disease) and FDA regulations. However, according to our interviews with academic and industry end-users, FBS usage continues to be prevalent within research segments. With the worldwide and US cell culture markets experiencing steady double-digit growth, the market landscape is poised for more competition, especially amongst companies able to expand their sales and marketing initiatives and develop new products adapted to different cell lines. From extensive interviews with cell culture purchasing decision-makers, we identify, analyze, and recommend specific strategic tactics for companies aiming to grow revenues and increase market share. For more information visit http://www.researchandmarkets.com/reports/c39059 CONTACT: Research and Markets Laura Wood press@researchandmarkets.com Fax: +353 1 4100 980 http://www.genengnews.com/news/bnitem.aspx?name=3136793 24 Jul 00 Trade Statistics: UK to US [Opinion (webmaster): The US has focused for years on tracing, containing, and eradicating live animal imports from the UK or other countries with acknowledged BSE like Belgium, including some 499 cattle and the Vermont sheep. This strategy does not acknowledge imports of rendered bovine products from England during the BSE period nor secondary products such as surgical catgut, which is to say surgical cowgut, or dairy cattle embryos, vaccines for veterinarian and human medicines. What has become of these? Mr. Singeltary, who lost his mother to CJD of unexplained origin a few years back and went on to became a well-known TSE activist, has tracked down voluminous pertinent import data through correspondence with UK officials and searches of government web sites. Imports of such products are frequently cited by Europeans in rating BSE risks in the US and in shutting out US exports. Many people's eyes glaze over when reviewing reams of sometimes older trade statistics. There is no proof that any of the imported products was contaminated with BSE nor if so, any evidence that any BSE product lead to infection in US livestock, surgical patients, or what not. Nonetheless, the data obtained by Mr. Singeltary establish that an appalling variety and tonnage of products that were imported by the US from the UK and othr BSE-affected countries during the peak of the BSE epidemic years.] 10 January 1990 COMMERCIAL IN CONFIDENCE NOT FOR PUBLICATION COMMITTEE ON SAFETY OF MEDICINES snip...see full text here ; http://www.mad-cow.org/00/jul00_dont_eat_sheep.html#hhh The documents below were provided by Terry S. Singeltary Sr on 8 May 2000. They are optically character read (scanned into computer) and so may contain typos and unreadable parts. TIP740203/l 0424 CONFIDENTIAL Did the US import fetal calf serum and vaccines from BSE-affected countries? 3002.10.0040: FETAL BOVINE SERUM (FBS) http://www.mad-cow.org/00/may00_news.html#aaa TWA LITTLE minute http://www.bseinquiry.gov.uk/files/yb/1989/02/22008001.pdf TSS
|
